financetom
World
financetom
/
World
/
Dow Edges Lower; Ventyx Biosciences Shares Plummet
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dow Edges Lower; Ventyx Biosciences Shares Plummet
Jul 29, 2024 11:52 AM

U.S. stocks were mostly higher toward the end of trading, while the Dow Jones index traded slightly lower on Monday.

The Dow traded down 0.04% to 40,571.88 while the NASDAQ rose 0.16% to 17,385.52. The S&P 500 also rose, gaining, 0.16% to 5,467.66.

Check This Out: Top 4 Energy Stocks That May Rocket Higher In Q3

Leading and Lagging Sectors

Consumer discretionary shares jumped by 1.8% on Monday.

In trading on Monday, energy shares fell by 1.2%.

Top Headline

The Dallas Fed Manufacturing index declined to -17.5 in July versus a reading of -15.1 in the prior month.

Equities Trading UP

                       

Lipella Pharmaceuticals Inc ( LIPO ). shares shot up 123% to $0.9265 after the company announced it commenced its Phase 2a trial for LP-310 in Oral Lichen Planus.

Shares of NLS Pharmaceutics AG ( NLSP ) got a boost, surging 38% to $0.2618 after the company announced a merger in which Kadimastem will become a wholly owned subsidiary of NLS.

Venus Concept Inc ( VERO ). shares were also up, gaining 26% to $0.8169 after the company received a medical device license from Health Canada to market its Venus Bliss MAX system.

Equities Trading DOWN

vTv Therapeutics Inc ( VTVT ). shares dropped 3251% to $15.92 after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program.

Shares of Cognition Therapeutics, Inc ( CGTX ). were down 35% to $1.5350. Cognition Therapeutics ( CGTX ) reported that participants in the proof-of-concept Phase 2 ‘SHINE' study who were treated with CT1812 for six months showed a consistent trend in cognitive improvement compared to placebo across all cognitive measures.

Ventyx Biosciences, Inc ( VTYX ). was down, falling 21% to $2.3350. The company released results from the Phase 2 trial of allosteric TYK2 inhibitor VTX958 in participants with moderately to severely active Crohn's disease, a type of inflammatory bowel disease that irritates and causes swelling in digestive tract.

Also Check This Out: This Analyst With 84% Accuracy Rate Sees More Than 10% Upside In Apple – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

Commodities

In commodity news, oil traded down 2.2% to $75.50 while gold traded down 0.2% at $2,376.50.

Silver traded down 1% to $27.75 on Monday, while copper fell 1% to $4.0820.

Euro zone

European shares closed mostly lower today. The eurozone's STOXX 600 fell 0.20%, Germany's DAX fell 0.53% and France's CAC 40 fell 0.98%. Spain's IBEX 35 Index fell 0.43%, while London's FTSE 100 rose 0.08%.

UK's net consumer credit increased by £1.2 billion over a month during June, a decline from the £1.5 billion gain recorded in May.

Asia Pacific Markets

Asian markets closed higher on Monday, with Japan's Nikkei 225 surging 2.13%, Hong Kong's Hang Seng Index gaining 1.28%, China's Shanghai Composite Index gaining 0.03% and India's S&P BSE Sensex rising 0.03%.

Singapore's Domestic Supply Price Index increased by 4.3% year-over-year in June, accelerating from a revised 2.7% gain in the prior month. Producer prices in Malaysia increased to 1.6% year-over-year for June. Profits earned by Chinese industrial firms climbed by 3.5% year-over-year to CNY 3,511.03 billion during the first six months of 2024.

Economics

The Dallas Fed Manufacturing index declined to -17.5 in July versus a reading of -15.1 in the prior month.

Now Read This: Northrop Grumman To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
GRAPHIC-Laggard European markets may be 2025's top recovery trade
GRAPHIC-Laggard European markets may be 2025's top recovery trade
Dec 15, 2024
* Investors call peak pessimism, start bargain hunting * Europe weighed down by political turmoil, tariff threats * Potential German stimulus, China recovery seen as catalysts By Naomi Rovnick LONDON, Dec 16 (Reuters) - The year ahead is shaping up badly for Europe with its financial markets already hit hard by U.S. tariff fears and political turmoil in France and...
Chips boost Japan's Nikkei, but caution ahead of key central bank meetings caps gains
Chips boost Japan's Nikkei, but caution ahead of key central bank meetings caps gains
Dec 15, 2024
TOKYO, Dec 16 (Reuters) - Japan's Nikkei share average climbed on Monday as chip-related shares were boosted by a rise in their U.S. peers, but investors' positioning ahead of major central bank decisions this week capped gains. The Nikkei added 0.2% to 39,533.55 by the midday break, while the broader Topix shed 0.04% to 2,745.46. While U.S. stocks closed the...
GLOBAL MARKETS-Asia wary of Fed rate future, China data disappoints
GLOBAL MARKETS-Asia wary of Fed rate future, China data disappoints
Dec 15, 2024
* Asian stock markets : https://tmsnrt.rs/2zpUAr4 * China retail data badly misses forecasts * Fed seen cutting 25bps, focus on future easing plans * BOE, BOJ and Norges seen on hold, Sweden to cut * Rising Treasury yields underpin dollar, pressure stocks (Adds China retail data in paragraph 2, updates prices to midday) By Wayne Cole SYDNEY, Dec 16 (Reuters)...
Asia wary of Fed rate future, China data disappoints
Asia wary of Fed rate future, China data disappoints
Dec 15, 2024
SYDNEY (Reuters) - Asian stock markets were in a wary mood on Monday as surging bond yields challenged equity valuations, particularly for the richly priced tech sector, in a week packed with central bank meetings and major economic data. Figures from China out on Monday showed retail sales rose just 3.0% in November, compared to a year earlier, well below...
Copyright 2023-2025 - www.financetom.com All Rights Reserved